Skip to content
Screener

Exelixis EXEL Total Current Assets

Total Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$64.67B+29.7%
Pfizer logo
PfizerPFE
$42.82B-6.6%
Kura Oncology logo
Kura OncologyKURA
$623.78M-13.9%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$392.33M+74.4%
Immunome logo
ImmunomeIMNM
$594.31M+83.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$756M-20.1%

Other financials

Income statement

See full
Revenue$628.7M+10.6%
Gross profit$608.0M+10.8%
Operating income$248.4M+16.3%
Net income$212.1M+14.7%
EPS (diluted)$0.82+26.2%

Balance sheet

See full
Cash & equivalents$281.4M+71.2%
Total debt$165.9M-7.7%
Total equity$1.8B-9.3%
Total assets$2.5B-6.9%

Cash flow

See full
Operating cash flow$307.7M+528%
CapEx$6.8M+140%
Free cash flow$300.9M+552%

Valuation

See full
Market cap$14.25B+40.4%
Enterprise value$14.14B+39.0%
P/E16.6×-0.3×
P/S5.9×+1.3×

Profitability

See full
Gross margin96.5%-0.1pp
Operating margin39.9%+8.5pp
Net margin35.3%+8.3pp
FCF margin48.1%+14.3pp

Returns & leverage

See full
Return on equity44.4%+15.4pp
Debt / equity0.1×0.0×
Current ratio3.5×-0.1×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Exelixis’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0000939767-26-000098
Line itemJune 30, 2026December 31, 2025
Trade receivables, net322,213286,916
Inventory28,72921,686
Prepaid expenses and other current assets60,49575,596
Total current assets1,250,8221,443,289
Non-current marketable securities544,930603,603
Property and equipment, net92,66598,960
Deferred tax assets, net294,205292,582
Goodwill63,68463,684

Item 1. Financial Statements.

FAQ

What is Exelixis's total current assets?
Exelixis (EXEL) reported total current assets of $1.25B in Q2 2026.
How has Exelixis's total current assets changed year-over-year?
Exelixis's total current assets increased by 5.9% year-over-year, from $1.18B to $1.25B.
What is the long-term trend for Exelixis's total current assets?
Over 5 years (2020 to 2025), Exelixis's total current assets has grown at a -0.0% compound annual growth rate (CAGR), from $1.45B to $1.44B.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Exelixis's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude